SecSonar.com

Cumberland Pharmaceuticals Inc. (CPIX)

Cumberland Pharmaceuticals Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Cumberland Pharmaceuticals Inc. (CPIX) is a Drug Manufacturers - Specialty & Generic company based in US with a market capitalization of $94.2M. Revenue grew 17.6% year-over-year and the company generated $4.8M in free cash flow. This page tracks CPIX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 91 employees · IPO Aug 11, 2009

Valuation

Valuation & price

$5.47 · as of May 17, 2026 · -20.7% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

3.78

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$6.89$4.40$1.90Jul 25Dec 25Jun 26Jul 7, 25$3.04Jul 9, 25$3.09Jul 11, 25$3.00Jul 15, 25$3.50Jul 17, 25$3.71Jul 21, 25$3.50Jul 23, 25$3.56Jul 25, 25$3.52Jul 29, 25$3.49Jul 31, 25$3.45Aug 4, 25$4.01Aug 6, 25$3.21Aug 8, 25$3.23Aug 12, 25$2.91Aug 14, 25$2.99Aug 18, 25$3.07Aug 20, 25$3.25Aug 22, 25$3.29Aug 27, 25$3.40Aug 29, 25$3.49Sep 3, 25$3.61Sep 5, 25$3.31Sep 9, 25$3.40Sep 11, 25$3.43Sep 15, 25$3.38Sep 17, 25$3.23Sep 19, 25$3.15Sep 23, 25$2.98Sep 25, 25$3.03Sep 29, 25$3.16Oct 1, 25$3.12Oct 3, 25$3.13Oct 7, 25$3.56Oct 9, 25$3.55Oct 13, 25$3.36Oct 16, 25$3.45Oct 20, 25$3.56Oct 22, 25$3.46Oct 24, 25$3.49Oct 28, 25$3.30Oct 30, 25$3.21Nov 3, 25$2.76Nov 5, 25$2.33Nov 7, 25$2.13Nov 11, 25$2.00Nov 13, 25$2.09Nov 17, 25$1.90Nov 19, 25$1.92Nov 21, 25$1.99Nov 25, 25$2.11Nov 28, 25$2.26Dec 2, 25$2.16Dec 5, 25$2.39Dec 9, 25$2.26Dec 11, 25$2.49Dec 15, 25$2.97Dec 17, 25$3.89Dec 19, 25$4.41Dec 23, 25$4.26Dec 26, 25$4.12Dec 30, 25$3.96Jan 2, 26$3.98Jan 6, 26$4.72Jan 8, 26$4.83Jan 12, 26$4.72Jan 14, 26$4.88Jan 16, 26$4.65Jan 21, 26$4.38Jan 23, 26$3.93Jan 28, 26$3.83Jan 30, 26$3.75Feb 3, 26$3.79Feb 5, 26$3.59Feb 9, 26$3.85Feb 11, 26$3.87Feb 13, 26$3.88Feb 18, 26$3.92Feb 20, 26$3.90Feb 24, 26$3.92Feb 26, 26$4.48Mar 2, 26$4.84Mar 4, 26$3.67Mar 6, 26$3.50Mar 10, 26$3.16Mar 12, 26$3.09Mar 16, 26$3.06Mar 19, 26$2.88Mar 23, 26$3.05Mar 25, 26$3.35Mar 27, 26$3.07Mar 31, 26$3.25Apr 2, 26$3.17Apr 7, 26$3.07Apr 9, 26$3.11Apr 13, 26$3.12Apr 15, 26$3.20Apr 17, 26$3.23Apr 21, 26$3.05Apr 23, 26$3.90Apr 27, 26$4.19Apr 29, 26$4.21May 1, 26$4.36May 5, 26$4.55May 8, 26$4.68May 12, 26$4.53May 14, 26$4.92May 18, 26$5.12May 20, 26$5.53May 22, 26$5.87May 27, 26$5.86May 29, 26$6.15Jun 2, 26$5.77Jun 4, 26$5.84Jun 8, 26$5.86Jun 10, 26$5.48Jun 12, 26$5.60Jun 16, 26$5.67Jun 18, 26$5.72Jun 23, 26$5.83Jun 29, 26$6.89
$1.9052-week range$6.89
Loading valuation history…

Fundamentals

Key fundamentals

$94.2M

Market cap

17.6%

Revenue growth (YoY)

85.0%

Gross margin

$4.8M

Free cash flow (USD)

-$1.3M

Net debt

Net cash position

6.4%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$33.0MFY 2017$41.2MFY 2018$40.7MFY 2019$34.4MFY 2020$37.4MFY 2021$36.0MFY 2022$42.0MFY 2023$39.6MFY 2024$37.9MFY 2025$44.5M
$33M$44.5M

Free cash flow by year

2016 → 2025

FY 2016$-1.6MFY 2017$-2.0MFY 2018$-1.2MFY 2019$2.8MFY 2020$3.3MFY 2021$6.0MFY 2022$6.4MFY 2023$5.6MFY 2024$-791.9KFY 2025$4.8M
-$1.6M$4.8M

Gross margin by year

2021 → 2025

FY 202175.5%FY 202278.3%FY 202384.7%FY 202482.6%FY 202585.0%
75.5%85.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 8, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAsset Purchase AgreementJul 1, 2026Filing
  • 8-K eventShareholder ApprovalJun 25, 2026Filing
  • Quarterly report10-Q FiledMay 8, 2026Filing
  • 8-K eventStrategic Transaction AnnouncedMay 5, 2026Filing
  • 8-K eventAnnual Shareholder MeetingApr 24, 2026Filing
  • 8-K eventAsset Purchase AgreementApr 23, 2026Filing

Questions

Frequently asked questions

What is Cumberland Pharmaceuticals Inc.'s market cap?

Cumberland Pharmaceuticals Inc. (CPIX) has a market capitalization of $94.2M.

What is CPIX's P/E ratio?

A meaningful P/E ratio is not available for CPIX — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is CPIX's price-to-book (P/B) ratio?

CPIX trades at 3.78 times book value per share.

Are insiders buying CPIX stock?

SEC Form 4 filings show no open-market insider buys at Cumberland Pharmaceuticals Inc. in the last 90 days (0 sells).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

INCR

InterCure Ltd.

$66.7M

BGM

BGM Group Ltd.

$64.2M

IXHL

Incannex Healthcare Limited

$39.6M

ZYBT

Zhengye Biotechnology Holding Limited

$39.4M

SCYX

SCYNEXIS, Inc.

$37.7M

ASRT

Assertio Holdings, Inc.

$151.4M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.